Document Detail

Knockdown of FoxM1 by siRNA interference decreases cell proliferation, induces cell cycle arrest and inhibits cell invasion in MHCC-97H cells in vitro.
MedLine Citation:
PMID:  20154714     Owner:  NLM     Status:  MEDLINE    
AIM: To investigate the effects of small interfering RNA (siRNA) knockdown of forkhead box M1 (FoxM1) on the proliferation and invasion capacities of human hepatocellular carcinoma MHCC-97H cells in vitro. METHODS: The expression levels of FoxM1 in human hepatocellular carcinoma samples, adjacent non-hepatocellular carcinoma liver samples and MHCC-97 cell lines were detected by RT-PCR and Western blotting. FoxM1 siRNA was transfected into MHCC-97H cells with Lipofectamine 2000. Cell growth was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and cell cycle analysis was performed by flow cytometry. Protein expression levels were evaluated by Western blotting. Anchorage-independent growth and the invasive potency of MHCC-97H cells were measured by soft agar colony formation and a transwell cell invasion assay, respectively. RESULTS: FoxM1 was over-expressed in hepatocellular carcinoma samples compared to adjacent non-hepatocellular carcinoma liver samples. FoxM1 siRNA was successfully transfected into MHCC-97H cells, resulting in the significant inhibition of FoxM1 mRNA and protein expression. Down-regulation of FoxM1 inhibited cell proliferation, caused cell cycle arrest, and decreased invasion of MHCC-97H cells. Compared with control and mock groups, the FoxM1 siRNA transfected cells showed decreased protein expressions of cyclin B1 and cyclin D1, whereas p27 protein expression was increased. Down-regulation of FoxM1 reduced the expression of matrix metalloproteinase-2 (MMP-2) and urokinase plasminogen activator (uPA). CONCLUSION: FoxM1 is functionally involved in hepatocellular carcinoma cell proliferation and invasion and is a potential target for hepatocellular carcinoma therapy.
Qi-fei Wu; Chang Liu; Ming-hui Tai; Dong Liu; Lei Lei; Rui-tao Wang; Min Tian; Yi L?
Related Documents :
18660794 - Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by...
1971134 - Nucleolar organizer regions in rat urinary bladder tumors induced by n-butyl-n-(4-hydro...
11210724 - Acetyl-seryl-aspartyl-lysyl-proline is a novel natural cell cycle regulator of renal ce...
7018724 - Distribution of immunoglobulin-containing cells and localization of secretory component...
7895534 - Polarized caco-2 cells. effect of reactive oxygen metabolites on enterocyte barrier fun...
8663244 - Metabolism of thrombospondin 2. binding and degradation by 3t3 cells and glycosaminogly...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-15
Journal Detail:
Title:  Acta pharmacologica Sinica     Volume:  31     ISSN:  1745-7254     ISO Abbreviation:  Acta Pharmacol. Sin.     Publication Date:  2010 Mar 
Date Detail:
Created Date:  2010-03-03     Completed Date:  2010-06-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100956087     Medline TA:  Acta Pharmacol Sin     Country:  United States    
Other Details:
Languages:  eng     Pagination:  361-6     Citation Subset:  IM    
Department of Hepatobiliary Surgery, the First Affiliated Hospital, Xi'an Jiaotong University, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Carcinoma, Hepatocellular / genetics,  metabolism*,  pathology
Cell Cycle*
Cell Proliferation*
Forkhead Transcription Factors / genetics*,  metabolism
Gene Expression Regulation, Neoplastic
Gene Silencing
Liver Neoplasms / genetics,  metabolism*,  pathology
Neoplasm Invasiveness / genetics
RNA, Small Interfering / genetics*
Reg. No./Substance:
0/FOXM1 protein, human; 0/Forkhead Transcription Factors; 0/RNA, Small Interfering

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Protective action of tetramethylpyrazine phosphate against dilated cardiomyopathy in cTnT(R141W) tra...
Next Document:  L-carnitine and taurine synergistically inhibit the proliferation and osteoblastic differentiation o...